Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AZD-8055
Cat. No.:
OB0225LY-0488
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
AZD-8055 is a selective mTOR inhibitor with the ability to regulate cell growth and metabolism.
Synonym:
AZD8055; 1009298-09-2; AZD 8055; (5-(2,4-Bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol; [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol; Benzenemethanol, 5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-
CAS No.:
1009298-09-2
Compound CID:
25262965
Formula:
C25H31N5O4
Formula Weight:
465.54
Specification
Relative Density:
1.248 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
AZD-8055 can be used in cancer-related studies or play an important role in exploring the important role of the mTOR pathway in cell proliferation.
Library Information
Targets:
PI3K/Akt/mTOR pathway
Receptors:
mTOR
Pathways:
Autophagy; Apoptosis; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-7
Plate Location:
c8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 96.66 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
3 mg/mL; 6.44 mM
ALogP:
3.274
HBA_Count:
6
HBD_Count:
1
Rotatable Bond:
5
